Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000315066-21-001796
Filing Date
2021-10-12
Accepted
2021-10-12 09:25:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G 6885
  Complete submission text file 0000315066-21-001796.txt   8499
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Subject) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92616 | Film No.: 211317247
SIC: 2834 Pharmaceutical Preparations